New AI model can identify neuroanatomical regions vulnerable to age-related changes

The aging brain undergoes structural and cellular changes that can impact function and increase susceptibility to neurodegenerative disorders like Alzheimer’s disease.

MedPage Today’s Most-Read Stories of 2023

This year was a big year in medical news, with groundbreaking drug approvals, unusual patient cases, and unprecedented changes to the healthcare workplace. As 2023

December 23, 2023

FDA details new ‘platform technology’ process that could accelerate cell and gene therapy approvals

The FDA on Tuesday released a long-awaited draft guidance explaining how companies can win designations for platform technologies, a regulatory step that could speed up

May 29, 2024

Risk Adjusted Net Present Value: What is the current valuation of Vertex Pharmaceuticals’s Suzetrigine

The revenue for Suzetrigine is expected to reach an annual total of $946 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.